Healios K.K.

TSE:4593.T

200 (JPY) • At close November 8, 2024
Bedrijfsnaam Healios K.K.
Symbool 4593.T
Munteenheid JPY
Prijs 200
Beurswaarde 18,026,200,400
Dividendpercentage 0%
52-weken bereik 114 - 264
Industrie Biotechnology
Sector Healthcare
CEO Dr. Tadahisa S. Kagimoto M.D.
Website https://www.healios.co.jp

An error occurred while fetching data.

Over Healios K.K.

Healios K.K. engages in the research and development, manufacture, and sale of cell therapy and regenerative medicine products in Japan, Europe, and the United States. The company is also developing cellular and tissue-based products comprising HLCR011 and HLCR012 that are iPSC regenerative medicines for the treatment of age-related macular degeneration;

Vergelijkbare Aandelen

MTI Ltd. logo

MTI Ltd.

9438.T

1,031 JPY

FALCO HOLDINGS Co., Ltd. logo

FALCO HOLDINGS Co., Ltd.

4671.T

2,387 JPY

Medius Holdings Co., Ltd. logo

Medius Holdings Co., Ltd.

3154.T

828 JPY

Kanamic Network Co.,LTD logo

Kanamic Network Co.,LTD

3939.T

534 JPY

I'rom Group Co., Ltd. logo

I'rom Group Co., Ltd.

2372.T

2,558 JPY

Fuji Pharma Co., Ltd. logo

Fuji Pharma Co., Ltd.

4554.T

1,293 JPY

Mizuho Medy Co.,Ltd. logo

Mizuho Medy Co.,Ltd.

4595.T

1,626 JPY

Data Horizon Corporation logo

Data Horizon Corporation

3628.T

415 JPY

Financiële Gegevens

Cijfers zijn in miljoenen (JPY)

Cijfers zijn in miljoenen (JPY)